...
首页> 外文期刊>Scandinavian journal of gastroenterology. >ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis.
【24h】

ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis.

机译:在非酒精性肝硬化中,ASAT / ALAT比率可提供独立于Child-Pugh类别,性别和年龄的预后信息。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: The aspartate amino transferase/alanine amino transferase (ASAT/ALAT) ratio is increased in cirrhosis. Some studies indicate that the ratio may provide prognostic information as well. The purpose of this study was to further elucidate the role of the ASAT/ALAT ratio as a predictor of survival by assessing it together with classical risk factors such as age, gender and Child-Pugh (CP) class in a mixed cohort of patients with cirrhosis. MATERIAL AND METHODS: Eighty-nine patients with alcoholic cirrhosis and 81 patients with non-alcoholic cirrhosis treated at Aker University Hospital between 1999 and 2004 were identified retrospectively. Survival data from these patients per August 2006 were retrieved from the Norwegian Death Registry. Clinical and biochemical data at time of diagnosis were assessed as predictors of survival using the Kaplan-Meier method and Cox regression models. RESULTS: Median ASAT/ALAT ratio was significantly higher in alcoholic cirrhosis (2.42) as compared with non-alcoholic cirrhosis (1.42). In both groups, a ratio above the median was predictive of poor outcome, p=0.024 and p=0.032, respectively. Other significant predictors of death were CP class (p<0.001), clinical decompensation (p<0.001) and age (p=0.001). Cox regression analyses showed that the ASAT/ALAT ratio was a predictor of death independently of CP class, gender and age in non-alcoholic, but not in alcoholic cirrhosis. The estimated increased hazard (risk of dying) in non-alcoholic cirrhosis was 5% (CI: 1-8%) per 0.10 increase in ASAT/ALAT ratio. CONCLUSIONS: A high ASAT/ALAT ratio is associated with increased mortality in cirrhosis. In non-alcoholic patients the ratio may provide prognostic information independently of classical risk factors.
机译:目的:肝硬化中天门冬氨酸氨基转移酶/丙氨酸氨基转移酶(ASAT / ALAT)的比例增加。一些研究表明该比率也可以提供预后信息。这项研究的目的是通过与年龄,性别和Child-Pugh(CP)类别等经典危险因素一起评估ASAT / ALAT比率,来进一步阐明ASAT / ALAT比率在生存预测中的作用。肝硬化。材料与方法:回顾性分析了1999年至2004年间在Aker大学医院接受治疗的89例酒精性肝硬化患者和81例非酒精性肝硬化患者。这些患者于2006年8月的生存数据可从挪威死亡登记处获取。使用Kaplan-Meier方法和Cox回归模型,将诊断时的临床和生化数据评估为生存的预测指标。结果:酒精性肝硬化的中位ASAT / ALAT比(2.42)明显高于非酒精性肝硬化(1.42)。两组中,高于中位数的比率均预示不良结果,分别为p = 0.024和p = 0.032。其他重要的死亡预测指标是CP级(p <0.001),临床代偿失调(p <0.001)和年龄(p = 0.001)。 Cox回归分析表明,在非酒精性肝硬化患者中,ASAT / ALAT比率是死亡的预测指标,与CP类别,性别和年龄无关,而在酒精性肝硬化中则不然。每增加0.10 ASAT / ALAT比率,非酒精性肝硬化的增加的危险(死亡风险)估计为5%(CI:1-8%)。结论:高的ASAT / ALAT比与肝硬化死亡率增加有关。在非酒精中毒患者中,该比率可提供独立于经典危险因素的预后信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号